¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"inositol cyclic 1,2-phosphate 1-phosphodiesterase"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inositol
    À̳ë½ÃÅç
  • cyclic
    ÁÖ±â-, ¼øÈ¯-, ȸ·Î-, °í¸®-
  • cyclic adenosine monophosphate
    °í¸®ÇüAMP
  • cyclic bleeding
    ÁÖ±âÃâÇ÷
  • cyclic compound
    °í¸®È­ÇÕ¹°
  • cyclic fluctuation
    ÁÖ±âÀûº¯µ¿
  • cyclic frequency
    ÁÖ±âÁ֯ļö
  • cyclic hematopoiesis
    Áֱ⼺Á¶Ç÷
  • cyclic hemorrhage
    ÁÖ±âÃâÇ÷
  • cyclic hydrocarbon
    °í¸®ÅºÈ­¼ö¼Ò
  • cyclic neutropenia
    ÁÖ±âÁß¼º±¸°¨¼Ò(Áõ)
  • cyclic parturition
    ÁÖ±âºÐ¸¸
  • cyclic periodicity
    ¼øÈ¯Áֱ⼺
  • cyclic schizophrenia
    ¼øÈ¯ÇüÁ¤½ÅºÐ¿­º´
  • cyclic strabismus
    ÁÖ±â»ç½Ã
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inositol
    À̳ë½ÃÅç
  • cyclic bleeding
    ÁÖ±âÃâÇ÷
  • cyclic
    ÁÖ±â-, ¼øÈ¯-, ȸ·Î-, °í¸®-
  • cyclic adenosine monophosphate
    °í¸®¿¡ÀÌ¿¥ÇÇ
  • cyclic compound
    (¢¡closed chain) ´ÝÈù»ç½½
  • cyclic ester
    °í¸®Çü¿¡½ºÅ׸£
  • cyclic fluctuation
    ¼øÈ¯º¯È­
  • cyclic frequency
    ÁÖ±âÁ֯ļö
  • cyclic hematopoiesis
    Áֱ⼺Á¶Ç÷
  • cyclic hemorrhage
    ÁÖ±âÃâÇ÷
  • cyclic hydrocarbon
    °í¸®Çüźȭ¼ö¼Ò
  • cyclic neutropenia
    ÁÖ±âÈ£Áß¼º¹éÇ÷±¸°¨¼ÒÁõ
  • cyclic parturition
    ÁÖ±âºÐ¸¸
  • cyclic periodicity
    ¼øÈ¯Áֱ⼺
  • cyclic schizophrenia
    ¼øÈ¯Á¤½ÅºÐ¿­º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • IP3 = inositol triphosphate
    À̳ë½ÃÅç Æ®¸®Æ÷½ºÆäÀÌÆ®
  • Inositol -1,4,5,-triphosphate
    À̳ë½ÃÅç-1,4,5-Æ®¸®Æ÷½ºÆäÀÌÆ®
  • Inositol triphosphate
    À̳ë½ÃÅç Æ®¸®Æ÷½ºÆäÀÌÆ®
  • inositol
    À̳ë½ÃÅç.
  • inositol-1,4,5-triphosphate(ip3)
    inositol-1,4,5-triphosphate(IP3)
  • phosphatidyl inositol
    Æ÷½ºÆÄƼµôÀ̳ë½ÃÅç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cyclic AMP ; cyclic adenosine mono pho sph ate
    °í¸®¸ð¾ç AMP.¾à¸®È¯ ½Ä±¸¾Æ³ë½Å¸ð³ëÆ÷½ºÆäÀÌÆ®, »çÀÌŬ¸¯AMP, cAMP cyclic aclenosine 3 , 5 monophate
  • glycosyl phosphatidyl inositol-linked proteins
    Glycosyl phosphatidyl inositol-linked proteins
  • inositol
    À̳ë½ÃÅç.
  • inositol-1,4,5-triphosphate(ip3)
    inositol-1,4,5-triphosphate(IP3)
  • phosphatidyl inositol
    Æ÷½ºÆÄƼµôÀ̳ë½ÃÅç
  • cAMP=>cyclic AMP
    ȯ½ÄAMP
  • cyclic AMP
    °í¸® AMP
  • cyclic AMP-dependent kinase
    °í¸® AMP ÀÇÁ¸¼º Ű³ªÁ¦
  • cyclic GMP
    °í¸® GMP.
  • cyclic adenosin 3-5-phosphate
    °í¸®¾Æµ¥³ë½Å 3-5Àλ꿰.
  • cyclic adenosine monophosphate
    °í¸® AMP
  • cyclic adenosinemonophosphate
    °í¸® AMP.
  • cyclic bleeding
    Áֱ⼺ ÃâÇ÷(ñÎÑ¢àõõóúì).
  • cyclic buccal ulceration
    Áֱ⼺ ±¸°­±Ë¾ç(ñÎÑ¢àõϢ˷Ï÷åË).
  • cyclic compound
    °í¸®Çü ȯ½ÄÈ­ÇÕ¹°(¡­úþü»ãÒûùùêÚª).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inositol
    À̳ë½ÃÅç
  • inositol phospholipid
    À̳ë½ÃÅç ÀÎÁöÁú(×òò·òõ)
  • "adenosine-3',5'-cyclic monophosphate"
    ¾Æµ¥³ë½Å-3'-5'-°í¸® ÀÏ(ìé)Àλ꿰(×òß«ç¤)
  • cyclic adenylic acid °í¸® ¾Æµ¥´Ñ»ê(ß«)
    "(ÔÒ)(ÔÒ) adenosine-3',5'-cyclic monophosphate,"
  • cyclic AMP receptor protein
    °í¸®AMP ¼ö¿ëü ´Ü¹éÁú(áôé»ô÷Ó±ÛÜòõ)
  • cyclic electron flow
    ¼øÈ¯(âàü») ÀüÀÚ(ï³í­) È帧
  • cyclic GMP
    "°í¸® GMP (ÔÒ) guanosine-3',5'-cyclic monophosphate,"
  • cyclic metabolic pathway
    ȸ·Î ´ë»ç°æ·Î(üÞÖØÓÛÞóÌèÖØ)
  • cyclic peptide
    °í¸®ÆéŸÀ̵å
  • cyclic permutation
    "¼øÈ¯¼ø¿­(âàü»â÷æê), (ÔÒ) circular permutation"
  • cyclic photophosphorylation
    ¼øÈ¯ ±¤ÀλêÈ­(âàü»ÎÃìÝß«ûù)
  • cyclic symmetry
    "°í¸®´ëĪ(Óßöà), (ÔÒ) rotational symmetry"
  • "uanosine-3', 5'-cyclic monophosphate"
    "±¸¾Æ³ë½Å-3`,5'-°í¸® ÀÏÀλê(ìé×òß«)"
  • nucleoside cyclic monophosphate
    °í¸® ÀÏÀλê(ìé×òß«) ´©Å¬¸®¿À»çÀ̵å
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cyclic frequency
    ÁÖ±âÁ֯ļö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IP3 Inositol tri-Phosphate
PI   1) Pulmonary Insufficience(Incompetence)
    = PR
  ...
PIP2 Phosphatidyl-Inositol 4,5-bi-Phosphate
IHP idiopathic hypoparathyroidism; idiopathic hypopituitarism; individualized health plan; inositol hexa...
INPP1 inositol polyphosphate 1-phosphatase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
cyclic AMP 3',5'-cyclic adenosine monophosphate
cyclic AMP 3',5'-cyclic monophosphate
cyclic GMP 3',5'-cyclic monophosphate
cyclic AMP Cyclic 3',5' adenosine monophosphate
cyclic GMP Cyclic guanosine 3',5' monophosphate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • inositol triphosphatase
    Àγë½ÃÅç Æ®¸®Æ÷½ºÆÄŸÁ¦
  • cyclic
    Áֱ⼺, ÁÖ±âÀÇ, Áֱ⼺ÀÇ, ¼øÈ¯ÀÇ, °í¸®ÀÇ
    Áֱ⼺ÀÇ, ¼øÈ¯ÀÇ, ȯ»óÀÇ. ÀÌ ¿ë¾î´Â ¿øÀÚÀÇ °í¸®¸¦ ÇÔÀ¯ÇÑ È­ÇÕ¹°¿¡ ´ëÇÏ¿© »ç¿ëµÈ´Ù.
  • cyclic AMP
    ȯ»ó AMP, °í¸®¸ð¾ç AMP, ȯ½Ä ¾Æµ¥³ë½Å ¸ð³ëÆ÷½ºÆäÀÌÆ®, »çÀ̱۸¯ AMP, cAMP
    cyclic adelenosine 3',5'-mono
  • cyclic AMP system
    ȯ»ó AMP °è
  • cyclic condition
    ÁÖ±âÀû »óÅÂ
  • cyclic frequency
    ÁÖ±â Á֯ļö
  • cyclic headache
    Áֱ⼺ µÎÅë
  • cyclic neutropenia
    Áֱ⼺ È£Áß±¸ °¨¼ÒÁõ
    °ñ¼öÀÇ ¼º¼÷ Á¤Áö·Î ÀÎÇÑ Áúº´ÀÌ´Ù. Áõ»óÀÌ ¹«°ú¸³±¸Áõ
  • cyclic spasm
    Áֱ⠿¬Ãà
  • idiopathic cyclic neutropenia
    Ư¹ß¼º Áֱ⼺ È£Áß±¸ °¨¼ÒÁõ
    ¸¸¼ºÇüÀÇ È£Áß±¸ °¨¼ÒÁõÀ¸·Î¼­, ÁÖ±âÀûÀ¸·Î ÀϾ´Â Àç¹ßÀ» Ư¡À¸·Î Çϸç, º´°¨, ¹ß¿­, ±¸³»¿° ¹× °¢Á¾ÀÇ °¨¿°À» µ¿¹ÝÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
inositol cyclic 1,2-phosphate 1-phosphodiesterase <enzyme> Converts inositol 1:2-cyclic phosphate to inositol 2-phosphate; do not confuse with inositol 1,2 cyclic-phosphate 2-phosphohydrolase see annexin III
Registry number: EC 3.1.4.-
Synonym: cins(1,2)p hydrolase II
(26 Jun 1999)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
cyclic inositol phosphate 1, 2 cyclic derivatives of inositol phosphatide that are invariably formed during enzymic hydrolysis of phosphatidyl inositol species. Have been proposed as second messengers in hormone activated pathways.
(18 Nov 1997)
glycosyl phosphatidyl inositol gPI anchor
meso-inositol 1. Generic term for any isomer of meso-inositol in which the hydroxyl groups are so arranged that the molecule as a whole possesses a plane of symmetry and is optically inactive.
2. Former name for myo-inositol.
(05 Mar 2000)
myo-inositol 1,2,3,5/4,6-Inositol;a constituent of various phosphatidylinositols and the most widely distributed form of inositol found in microorganisms, higher plants, and animals. In plants, it is found as phytic acid and as phytin; partially phosphorylated and free forms occur throughout nature, and in many tissues.
(05 Mar 2000)
myo-inositol 1,4,5-triphosphate phosphatase <enzyme> Neutral pH optimum; magnesium dependent
Registry number: EC 3.1.-
Synonym: i-p3ase, inositol 1,4,5-triphosphate phosphatase
(26 Jun 1999)
myo-inositol-1 (or 4)-monophosphatase <enzyme> Acts on inositol 1-phosphate, inositol 3-phosphate or inositol 4-phosphate; suhb gene product from e. Coli has been sequenced; do not confuse with impa protein
Registry number: EC 3.1.3.25
Synonym: 1l-myo-inositol-1-phosphate phosphohydrolase, inositol-1-phosphate phosphohydrolase, myo-inositol-1-phosphatase, inositol phosphatase, myo-inositol monophosphatase, 1l-myo-inositol-1-phosphatase, inositol monophosphatase, suhb gene product, inositol monophosphate phosphatase impa
(26 Jun 1999)
myo-inositol-1-phosphate dehydrogenase <enzyme> Requires nad+, forms ribulose 5-phosphate
Registry number: EC 1.1.1.-
Synonym: inositol-1-phosphate dehydrogenase
(26 Jun 1999)
myo-inositol-1-phosphate synthase <enzyme> An enzyme that catalyses the formation of myo-inositol-1-phosphate from glucose-6-phosphate in the presence of NAD.
Chemical name: 1L-myo-Inositol-1-phosphate lyase (isomerizing)
Registry number: EC 5.5.1.4
(12 Dec 1998)
myo-inositol-4-phosphatase <enzyme> Brain and liver enzymes are li-sensitive
Registry number: EC 3.1.3.-
(26 Jun 1999)
myo-inositol-trisphosphate 3-kinase <enzyme> Converts inositol triphosphate to 1,3,4,5-tetrakisphosphate
Registry number: EC 2.7.1.127
Synonym: inositol 1,4,5-triphosphate kinase, 1,4,5-intp kinase, inositol(1,4,5)p3 3-kinase, myo-inositol 1,4,5-triphosphate-3-kinase, inositol 1,4,5-trisphosphate kinase
(26 Jun 1999)
myo-inositol-trisphosphate 6-kinase <enzyme> Forms inositol 1,3,4,6-tetrakisphosphate and inositol 1,3,4,5-tetrakisphosphate in a ratio of 5:1
Registry number: EC 2.7.1.133
Synonym: inositol 1,3,4-p3 kinase, ins 1,3,4-p3 kinase, myo-inositol 1,3,4-tris phosphate 6-kinase, inositol-1,3,4-trisphosphate 5,6-kinase, inositol-trisphosphate 6-kinase
(26 Jun 1999)
SH2-containing inositol phosphatase <enzyme> 145-kD protein with both phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate polyphosphate 5-phosphatase activity; associates with shc in response to multiple cytokines; genbank u39203 and y14385
Registry number: EC 3.1.3.-
Synonym: ship protein, inpp5d gene product, sh2- and sh3-containing inositol polyphosphate-5-phosphatase, pp135 ship, ship2 protein
(26 Jun 1999)
D-myo-inositol-3-phosphate synthase <enzyme> Catalyses conversion of d-glucose-6-phosphate to d-myo-inositol-3-phosphate
Registry number: EC 5.5.1.-
Synonym: inositol-3-phosphate synthase, ins3p synthase
(26 Jun 1999)
inositol A cyclic hexahydric alcohol with 6 possible isomers. The biologically active form is myo inositol.
(18 Nov 1997)
inositol 1,2,3,4,6-pentakisphosphate-2-phoshomonoesterase <enzyme> Metabolises ins(1,2,3,4,6)p5 to ins(1,3,4,6)p4
Registry number: EC 3.1.3.-
Synonym: 1,2,3,4,5-insp5-2-p monoesterase
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inositol
    À̳ë½ÃÅç;±ÙÀ°´ç;(ºñŸ¹Î Bº¹ÇÕüÀÇ Çϳª
  • cyclic adenosine monophosphate
    =CYCLIC AMP
  • cyclic chorus
    À±¹«Ã¢(Dionysus Á¦´Ü µÑ·¹¸¦ µµ´Â)
  • cyclic flower
    À±»ýÈ­
  • cyclic poets
    È£¸Ó¿¡ ÀÌ¾î Æ®·ÎÀÌ ÀüÀïÀ» À¼Àº ½ÃÀεé
  • cyclic,-clical
    ¼øÈ¯±âÀÇ;ÁÖ±âÀûÀÎ;(ÀÏ·ÃÀÇ)»ç½Ã(Àü¼³)ÀÇ;cyclically
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á